COLO-B.CO vs. NOVO-B.CO
Compare and contrast key facts about Coloplast A/S (COLO-B.CO) and Novo Nordisk A/S (NOVO-B.CO).
Performance
COLO-B.CO vs. NOVO-B.CO - Performance Comparison
Loading graphics...
COLO-B.CO vs. NOVO-B.CO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
COLO-B.CO Coloplast A/S | -18.96% | -27.73% | 4.47% | -2.40% | -27.80% | 26.10% | 14.67% | 39.66% | 25.89% | 6.74% |
NOVO-B.CO Novo Nordisk A/S | -24.65% | -46.40% | -9.59% | 50.74% | 29.53% | 75.62% | 12.77% | 32.92% | -8.60% | 35.35% |
Returns By Period
In the year-to-date period, COLO-B.CO achieves a -18.96% return, which is significantly higher than NOVO-B.CO's -24.65% return. Over the past 10 years, COLO-B.CO has underperformed NOVO-B.CO with an annualized return of 1.53%, while NOVO-B.CO has yielded a comparatively higher 5.27% annualized return.
COLO-B.CO
- 1D
- 1.47%
- 1M
- -8.29%
- YTD
- -18.96%
- 6M
- -18.07%
- 1Y
- -36.61%
- 3Y*
- -18.68%
- 5Y*
- -11.93%
- 10Y*
- 1.53%
NOVO-B.CO
- 1D
- 2.60%
- 1M
- 5.86%
- YTD
- -24.65%
- 6M
- -33.97%
- 1Y
- -46.86%
- 3Y*
- -22.16%
- 5Y*
- 4.16%
- 10Y*
- 5.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
COLO-B.CO vs. NOVO-B.CO — Risk / Return Rank
COLO-B.CO
NOVO-B.CO
COLO-B.CO vs. NOVO-B.CO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Coloplast A/S (COLO-B.CO) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| COLO-B.CO | NOVO-B.CO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -1.44 | -0.88 | -0.56 |
Sortino ratioReturn per unit of downside risk | -2.05 | -1.12 | -0.93 |
Omega ratioGain probability vs. loss probability | 0.75 | 0.84 | -0.10 |
Calmar ratioReturn relative to maximum drawdown | -0.90 | -0.87 | -0.04 |
Martin ratioReturn relative to average drawdown | -1.70 | -1.48 | -0.22 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| COLO-B.CO | NOVO-B.CO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.44 | -0.88 | -0.56 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.46 | 0.11 | -0.57 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.06 | 0.16 | -0.10 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.52 | 0.51 | +0.01 |
Correlation
The correlation between COLO-B.CO and NOVO-B.CO is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
COLO-B.CO vs. NOVO-B.CO - Dividend Comparison
COLO-B.CO's dividend yield for the trailing twelve months is around 5.19%, more than NOVO-B.CO's 4.94% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO-B.CO Coloplast A/S | 5.19% | 4.21% | 2.80% | 2.72% | 2.46% | 1.65% | 1.94% | 2.06% | 2.64% | 3.04% | 2.83% | 2.24% |
NOVO-B.CO Novo Nordisk A/S | 4.94% | 3.58% | 1.59% | 1.01% | 1.19% | 1.27% | 2.02% | 2.11% | 2.64% | 2.27% | 3.69% | 1.25% |
Drawdowns
COLO-B.CO vs. NOVO-B.CO - Drawdown Comparison
The maximum COLO-B.CO drawdown since its inception was -59.68%, smaller than the maximum NOVO-B.CO drawdown of -76.75%. Use the drawdown chart below to compare losses from any high point for COLO-B.CO and NOVO-B.CO.
Loading graphics...
Drawdown Indicators
| COLO-B.CO | NOVO-B.CO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.68% | -76.75% | +17.07% |
Max Drawdown (1Y)Largest decline over 1 year | -41.04% | -54.94% | +13.90% |
Max Drawdown (5Y)Largest decline over 5 years | -59.68% | -76.75% | +17.07% |
Max Drawdown (10Y)Largest decline over 10 years | -59.68% | -76.75% | +17.07% |
Current DrawdownCurrent decline from peak | -57.56% | -75.38% | +17.82% |
Average DrawdownAverage peak-to-trough decline | -12.20% | -15.80% | +3.60% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.75% | 32.14% | -10.39% |
Volatility
COLO-B.CO vs. NOVO-B.CO - Volatility Comparison
The current volatility for Coloplast A/S (COLO-B.CO) is 7.75%, while Novo Nordisk A/S (NOVO-B.CO) has a volatility of 9.07%. This indicates that COLO-B.CO experiences smaller price fluctuations and is considered to be less risky than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| COLO-B.CO | NOVO-B.CO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.75% | 9.07% | -1.32% |
Volatility (6M)Calculated over the trailing 6-month period | 19.42% | 40.80% | -21.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.64% | 55.40% | -29.76% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.12% | 38.25% | -12.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.71% | 32.32% | -7.61% |
Financials
COLO-B.CO vs. NOVO-B.CO - Financials Comparison
This section allows you to compare key financial metrics between Coloplast A/S and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities